QUARTERLY RESULTS FDC Q3 Results: Net Profit Declines 23.5% YoY to Rs 28.3 crore, revenue flat at Rs 465 crore Feb 5, 2026
CORPORATES FDC receives ANDA approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution USP Oct 4, 2025
FDC shares drop over 3% as Q4 EBITDA falls 4.2% YoY to Rs 54 crore, net profit down 16.4% YoY May 29, 2025